Finolex Industries Ltd. — Regulatory Filings 2022

Nov 18, 2022

==> picture [452 x 74] intentionally omitted <==

FIL/SEC/SEs/2022-23/075

18[th ] November, 2022

National Stock Exchange of India Limited Manager – Listing 5, Exchange Plaza, Bandra-Kurla Complex, Bandra (East), Mumbai 400051 Scrip Code: FINPIPE

BSE Limited Manager – Listing Registered Office: Floor 25 P.J. Towers, Dalal Street, Mumbai 400 001 Scrip Code: 500940

Sub: Outcome of investors/analysts meeting held on 17[th] November, 2022

Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Regulations”)

Dear Sir/Madam,

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that, the Company’s Senior Management interacted with the following investors / analysts in a physical meeting held on 17[th] November, 2022.

1. JP Morgan;

2. Axis Mutual Fund;

3. Bajaj Allianz Life Insurance Company;

4. Mirae Asset Investments Managers (India) Private Limited;

5. Pictet Asset Management Limited; &

6. Eurizon.

Please note, neither the presentation nor unpublished price sensitive information was made / discussed during the meeting with investors / analysts. The discussion took place in respect of Company’s overview.

This information is also being uploaded on the Company’s website at https://www.finolexpipes.com/

You are requested to take the above on your records.

Thanking you,

Yours sincerely,

For Finolex Industries Limited

ASHUTOSH Digitally signed by ASHUTOSH BHALCHANDRA BHALCHAND KULKARNI Date: 2022.11.18 17:16:02 RA KULKARNI +05'30'

Ashutosh Kulkarni Company Secretary & Compliance Officer M. No.: A18549

==> picture [452 x 68] intentionally omitted <==